tiprankstipranks
Innate Pharma (IPHA)
NASDAQ:IPHA
US Market
IPHA
Innate Pharma
RESEARCH TOOLSreports

Innate Pharma (IPHA) Ratios

132 Followers

Innate Pharma Ratios

IPHA's free cash flow for Q4 2025 was €-8.90. For the 2025 fiscal year, IPHA's free cash flow was decreased by € and operating cash flow was €15.14. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.27 1.27 2.60 3.73 3.38
Quick Ratio
 1.27 1.27 2.60 3.73 3.38
Cash Ratio
 0.77 0.77 2.01 1.78 2.04
Solvency Ratio
 -0.57 -0.54 -0.46 -0.02 -0.08
Operating Cash Flow Ratio
 -1.44 -1.38 -0.21 -0.82 -0.46
Short-Term Operating Cash Flow Coverage
 -5.99 -5.76 -0.82 -3.85 -15.17
Net Current Asset Value
€ -37.71M€ -37.70M€ -16.48M€ 15.72M€ -13.88M
Leverage Ratios
Debt-to-Assets Ratio
 0.36 0.36 0.28 0.23 0.20
Debt-to-Equity Ratio
 -1.04 -1.04 3.51 0.77 0.78
Debt-to-Capital Ratio
 25.98 25.98 0.78 0.43 0.44
Long-Term Debt-to-Capital Ratio
 -1.74 -1.74 0.72 0.37 0.42
Financial Leverage Ratio
 -2.89 -2.89 12.57 3.38 3.84
Debt Service Coverage Ratio
 -4.68 -4.29 -5.21 -0.20 -7.92
Interest Coverage Ratio
 -19.30 -17.83 -91.12 -19.80 -199.39
Debt to Market Cap
 0.22 0.17 0.21 0.18 0.14
Interest Debt Per Share
 0.28 0.29 0.39 0.48 0.53
Net Debt to EBITDA
 0.09 0.13 0.75 16.70 3.42
Profitability Margins
Gross Profit Margin
100.00%100.00%100.00%10.83%10.42%
EBIT Margin
-2161.00%-1976.79%-387.49%-13.35%-100.02%
EBITDA Margin
-2111.34%-2028.01%-371.69%-3.54%-21.29%
Operating Profit Margin
-2161.00%-1916.94%-408.64%-24.41%-99.57%
Pretax Profit Margin
-1987.15%-1764.51%-391.97%-14.59%-100.52%
Net Profit Margin
-1764.51%-1694.87%-391.97%-14.59%-100.74%
Continuous Operations Profit Margin
-1764.51%-1694.87%-391.97%-14.59%-100.52%
Net Income Per EBT
88.80%96.05%100.00%100.00%100.23%
EBT Per EBIT
91.96%92.05%95.92%59.75%100.95%
Return on Assets (ROA)
-78.41%-75.35%-44.54%-4.32%-27.95%
Return on Equity (ROE)
593.93%217.73%-560.01%-14.59%-107.30%
Return on Capital Employed (ROCE)
-231.02%-205.02%-66.06%-9.35%-34.48%
Return on Invested Capital (ROIC)
-163.30%-134.69%-59.43%-8.77%-34.05%
Return on Tangible Assets
-78.41%-75.35%-44.54%-4.33%-28.16%
Earnings Yield
-45.06%-35.47%-34.35%-3.55%-20.96%
Efficiency Ratios
Receivables Turnover
 0.22 0.22 7.68 1.12 18.36
Payables Turnover
 1.36 0.00 0.00 6.54 3.78
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 0.64 0.64 2.46 8.21 6.75
Asset Turnover
 0.04 0.04 0.11 0.30 0.28
Working Capital Turnover Ratio
 0.12 0.09 0.16 0.50 0.74
Cash Conversion Cycle
 1.36K 1.62K 47.52 271.16 -76.60
Days of Sales Outstanding
 1.62K 1.62K 47.52 326.94 19.88
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 267.56 0.00 0.00 55.78 96.48
Operating Cycle
 1.62K 1.62K 47.52 326.94 19.88
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.58 -0.57 -0.09 -0.39 -0.24
Free Cash Flow Per Share
 -0.58 -0.57 -0.09 -0.42 -0.25
CapEx Per Share
 <0.01 <0.01 <0.01 0.03 0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.06 1.07 1.06
Dividend Paid and CapEx Coverage Ratio
 -376.82 -376.82 -17.64 -13.85 -17.07
Capital Expenditure Coverage Ratio
 -376.82 -376.82 -17.64 -13.85 -17.07
Operating Cash Flow Coverage Ratio
 -2.34 -2.25 -0.22 -0.82 -0.45
Operating Cash Flow to Sales Ratio
 -18.93 -18.18 -0.55 -0.63 -0.33
Free Cash Flow Yield
-47.25%-38.15%-5.06%-16.38%-7.31%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -2.05 -2.82 -2.91 -28.15 -4.77
Price-to-Sales (P/S) Ratio
 37.14 47.79 11.41 4.11 4.81
Price-to-Book (P/B) Ratio
 -4.65 -6.14 16.30 4.11 5.12
Price-to-Free Cash Flow (P/FCF) Ratio
 -1.96 -2.62 -19.76 -6.10 -13.67
Price-to-Operating Cash Flow Ratio
 -1.91 -2.63 -20.88 -6.54 -14.48
Price-to-Earnings Growth (PEG) Ratio
 -0.02 0.21 >-0.01 0.32 -0.17
Price-to-Fair Value
 -4.65 -6.14 16.30 4.11 5.12
Enterprise Value Multiple
 -1.67 -2.26 -2.32 -99.16 -19.16
Enterprise Value
 106.42M 127.66M 108.62M 182.35M 235.28M
EV to EBITDA
 -1.81 -2.92 -2.32 -99.16 -19.16
EV to Sales
 38.18 45.81 8.61 3.51 4.08
EV to Free Cash Flow
 -2.01 -2.51 -14.91 -5.22 -11.60
EV to Operating Cash Flow
 -2.02 -2.52 -15.75 -5.60 -12.28
Tangible Book Value Per Share
 -0.24 -0.24 0.11 0.51 0.66
Shareholders’ Equity Per Share
 -0.24 -0.24 0.11 0.62 0.68
Tax and Other Ratios
Effective Tax Rate
 0.05 0.12 0.00 0.00 0.00
Revenue Per Share
 0.03 0.03 0.16 0.62 0.72
Net Income Per Share
 -0.54 -0.53 -0.61 -0.09 -0.73
Tax Burden
 0.89 0.96 1.00 1.00 1.00
Interest Burden
 0.92 1.01 1.01 1.09 1.00
Research & Development to Revenue
 15.65 15.03 4.12 1.08 0.90
SG&A to Revenue
 6.72 3.95 0.95 0.23 0.25
Stock-Based Compensation to Revenue
 0.56 0.00 0.31 0.08 0.07
Income Quality
 1.07 1.07 0.14 4.30 0.33
Currency in EUR